Accovion establishes two additional subsidiaries in the Czech Republic and in Russia

Accovion is a premier full service European CRO known for its expertise in managing and conducting international clinical trials. Accovion supports local and global projects of all types and phases for the pharmaceutical, biotechnology and medical device industries. Its services include study planning and management, clinical monitoring, pharmacovigilance including post-marketing safety, data management, biostatistics, statistical programming, medical writing and electronic publishing.

In 2010, Accovion continued to grow internationally by establishing two additional subsidiaries in the Czech Republic and in Russia.

Ivana Waller, Chief Operating Officer of Accovion, stated: "We have been conducting clinical research activities for our clients in the Czech Republic and Russia for some time now. Our new affiliate offices help strengthen our base, give us better access to the local clinical research talent and enable us to be even more responsive to our clients' growing needs. We were very pleased to bring on board two experienced Managing Directors - Dr. Jiri Skopek for our Prague office and Dr. Nikolay Odintsov for our Moscow office. I am confident that under their business leadership and with their clinical research expertise, our operations in both countries will continue to flourish."

In 2011, Accovion's strategic plan includes formalizing activities in several other European countries by establishing additional subsidiaries. With its active, well-planned expansion, Accovion aims to offer its clients a broader spectrum of country-specific clinical research expertise, all under one roof and all providing the quality services that Accovion is known for.